Dirui Industrial Co Ltd - Asset Resilience Ratio
Dirui Industrial Co Ltd (300396) has an Asset Resilience Ratio of 6.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Dirui Industrial Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Dirui Industrial Co Ltd's Asset Resilience Ratio has changed over time. See Dirui Industrial Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Dirui Industrial Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300396 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥180.62 Million | 6.89% |
| Total Liquid Assets | CN¥180.62 Million | 6.89% |
Asset Resilience Insights
- Limited Liquidity: Dirui Industrial Co Ltd maintains only 6.89% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dirui Industrial Co Ltd Industry Peers by Asset Resilience Ratio
Compare Dirui Industrial Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Dirui Industrial Co Ltd (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Dirui Industrial Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.50% | CN¥180.32 Million ≈ $26.39 Million |
CN¥2.77 Billion ≈ $405.64 Million |
+6.50pp |
| 2023-12-31 | 0.01% | CN¥185.85K ≈ $27.20K |
CN¥3.32 Billion ≈ $485.93 Million |
-5.83pp |
| 2022-12-31 | 5.83% | CN¥170.61 Million ≈ $24.96 Million |
CN¥2.93 Billion ≈ $428.06 Million |
-11.91pp |
| 2021-12-31 | 17.74% | CN¥421.40 Million ≈ $61.66 Million |
CN¥2.38 Billion ≈ $347.63 Million |
+13.60pp |
| 2019-12-31 | 4.14% | CN¥85.43 Million ≈ $12.50 Million |
CN¥2.06 Billion ≈ $301.78 Million |
+4.13pp |
| 2018-12-31 | 0.01% | CN¥171.21K ≈ $25.05K |
CN¥1.99 Billion ≈ $291.04 Million |
0.00pp |
| 2017-12-31 | 0.01% | CN¥212.70K ≈ $31.12K |
CN¥1.85 Billion ≈ $270.86 Million |
0.00pp |
| 2016-12-31 | 0.01% | CN¥248.03K ≈ $36.30K |
CN¥1.86 Billion ≈ $271.94 Million |
0.00pp |
| 2015-12-31 | 0.02% | CN¥274.84K ≈ $40.22K |
CN¥1.77 Billion ≈ $258.56 Million |
-5.72pp |
| 2014-12-31 | 5.73% | CN¥60.00 Million ≈ $8.78 Million |
CN¥1.05 Billion ≈ $153.17 Million |
+1.15pp |
| 2013-12-31 | 4.58% | CN¥25.00 Million ≈ $3.66 Million |
CN¥546.01 Million ≈ $79.90 Million |
-- |
About Dirui Industrial Co Ltd
Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents. It also offers urine and biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrat… Read more